Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/1839

TDMS Study 05057-02 Pathology Tables



                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                            HC YELLOW 4


NTP Experiment-Test: 05057-02                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/08/94
Route: DOSED FEED                                                                                                 Time: 06:16:55




       Facility:  TSI Mason Research

       Chemical CAS #:  5982043-8

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05057-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            HC YELLOW 4                                        Date: 09/08/94  
Route: DOSED FEED                                                                                                 Time: 06:16:55  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATE     0.5%         1.0%                                                   
                                                   D 61UF       61LF         61HF                                                   
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          70           70           70                                                  
  Scheduled Sacrifice                                 20           20           20                                                  
  Early Deaths                                                                                                                      
    Dead                                               4            2            2                                                  
    Moribund                                           3           10            5                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                43           38           43                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (46)         (3)          (48)                                                
      Inflammation, Chronic                           10 (22%)                   4 (8%)                                             
   Liver                                              (50)         (18)         (50)                                                
      Basophilic Focus                                                           1 (2%)                                             
      Clear Cell Focus                                 2 (4%)                                                                       
      Fatty Change                                     2 (4%)                                                                       
      Inflammation, Chronic Active                    17 (34%)                  23 (46%)                                            
      Necrosis                                         4 (8%)       1 (6%)      13 (26%)                                            
   Mesentery                                          (2)          (1)          (1)                                                 
      Fibrosis                                         1 (50%)                                                                      
      Inflammation, Chronic Active                     1 (50%)                                                                      
      Necrosis                                         1 (50%)                                                                      
   Pancreas                                           (48)         (3)          (49)                                                
      Inflammation, Chronic                           25 (52%)                  22 (45%)                                            
   Salivary Glands                                    (50)         (2)          (50)                                                
      Inflammation, Chronic                            4 (8%)                                                                       
      Inflammation, Chronic Active                    33 (66%)      1 (50%)     32 (64%)                                            
   Stomach, Forestomach                               (49)         (7)          (50)                                                
      Acanthosis                                       1 (2%)                    3 (6%)                                             
      Hyperkeratosis                                   1 (2%)                    2 (4%)                                             
      Hyperplasia, Basal Cell                                                    2 (4%)                                             
      Hyperplasia, Pseudoepitheliomatous                                         1 (2%)                                             
      Inflammation, Chronic Active                     3 (6%)       1 (14%)      4 (8%)                                             
      Ulcer                                                                      1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05057-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            HC YELLOW 4                                        Date: 09/08/94  
Route: DOSED FEED                                                                                                 Time: 06:16:55  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATE     0.5%         1.0%                                                   
                                                   D 61UF       61LF         61HF                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (3)          (50)                                                
      Hyperplasia                                      3 (6%)                                                                       
   Adrenal Gland, Medulla                             (49)         (3)          (47)                                                
      Hyperplasia                                      1 (2%)                    1 (2%)                                             
   Islets, Pancreatic                                 (49)         (3)          (49)                                                
      Hyperplasia                                      1 (2%)                                                                       
   Pituitary Gland                                    (42)                      (45)                                                
      Pars Distalis, Hyperplasia                       9 (21%)                   8 (18%)                                            
   Thyroid Gland                                      (48)         (49)         (50)                                                
      Inflammation, Acute                                                        2 (4%)                                             
      Inflammation, Chronic                            1 (2%)       6 (12%)      6 (12%)                                            
      Inflammation, Chronic Active                                               2 (4%)                                             
      C-Cell, Hyperplasia                                                        1 (2%)                                             
      Follicle, Cyst                                   1 (2%)       1 (2%)       1 (2%)                                             
      Follicle, Pigmentation                                       48 (98%)     50 (100%)                                           
      Follicular Cell, Hyperplasia                                  3 (6%)      13 (26%)                                            
      Follicular Cell, Pigmentation                                49 (100%)    50 (100%)                                           
      Interstitium, Pigmentation                                   46 (94%)     50 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ovary                                              (50)         (47)         (50)                                                
      Angiectasis                                                   2 (4%)       4 (8%)                                             
      Cyst                                            14 (28%)     17 (36%)     23 (46%)                                            
      Cyst, Multiple                                   4 (8%)       4 (9%)       1 (2%)                                             
      Hemorrhage                                                    9 (19%)     11 (22%)                                            
      Inflammation, Chronic                           16 (32%)      4 (9%)       2 (4%)                                             
      Mineralization                                                1 (2%)       2 (4%)                                             
      Thrombosis                                                                 1 (2%)                                             
   Uterus                                             (50)         (24)         (50)                                                
      Endometriosis                                    1 (2%)                                                                       
      Endometrium, Hydrometra                                                   10 (20%)                                            
      Endometrium, Hyperplasia                        41 (82%)     12 (50%)     36 (72%)                                            
      Endometrium, Metaplasia, Squamous                                          1 (2%)                                             
      Endometrium, Thrombosis                          1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05057-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            HC YELLOW 4                                        Date: 09/08/94  
Route: DOSED FEED                                                                                                 Time: 06:16:55  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATE     0.5%         1.0%                                                   
                                                   D 61UF       61LF         61HF                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (3)          (50)                                                
      Myelofibrosis                                   36 (72%)                  42 (84%)                                            
   Lymph Node                                         (49)         (15)         (49)                                                
      Renal, Hyperplasia, Lymphoid                                  1 (7%)                                                          
   Lymph Node, Mesenteric                             (45)         (10)         (44)                                                
      Infiltration Cellular, Histiocyte               26 (58%)      2 (20%)     23 (52%)                                            
   Spleen                                             (49)         (17)         (50)                                                
      Hematopoietic Cell Proliferation                 6 (12%)      3 (18%)      2 (4%)                                             
      Hyperplasia, Lymphoid                           11 (22%)      4 (24%)      3 (6%)                                             
      Pigmentation                                                               1 (2%)                                             
   Thymus                                             (43)         (6)          (41)                                                
      Cyst                                             4 (9%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (4)          (50)                                                
      Joint, Tarsal, Hyperostosis                                   1 (25%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (5)          (50)                                                
      Gliosis                                                       1 (20%)                                                         
      Thalamus, Mineralization                        34 (68%)      2 (40%)     19 (38%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (8)          (50)                                                
      Hemorrhage                                       3 (6%)                    5 (10%)                                            
      Alveolar Epithelium, Hyperplasia                 1 (2%)                    1 (2%)                                             
   Nose                                               (47)         (3)          (46)                                                
      Inflammation, Acute                              9 (19%)      1 (33%)      2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05057-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            HC YELLOW 4                                        Date: 09/08/94  
Route: DOSED FEED                                                                                                 Time: 06:16:55  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATE     0.5%         1.0%                                                   
                                                   D 61UF       61LF         61HF                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (4)          (50)                                                
      Inflammation, Chronic                           45 (90%)      3 (75%)     48 (96%)                                            
      Metaplasia, Osseous                                                        1 (2%)                                             
   Urinary Bladder                                    (48)         (4)          (49)                                                
      Inflammation, Chronic                           43 (90%)      2 (50%)     39 (80%)                                            
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05057-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            HC YELLOW 4                                        Date: 09/08/94  
Route: DOSED FEED                                                                                                 Time: 06:16:55  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATE     0.5%         1.O%                                                   
                                                   D 61UM       61LM         61HM                                                   
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          70           70           70                                                  
  Scheduled Sacrifice                                 20           20           20                                                  
  Early Deaths                                                                                                                      
    Dead                                              14           10            5                                                  
    Moribund                                           8           10            9                                                  
    Accident                                                                     1                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                28           29           35                                                  
  Missing                                                           1                                                               
  Animals Examined Microscopically                    50           49           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (39)         (9)          (46)                                                
      Inflammation, Chronic                            3 (8%)                    4 (9%)                                             
   Intestine Small, Ileum                             (41)         (14)         (45)                                                
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
   Liver                                              (49)         (22)         (48)                                                
      Basophilic Focus                                                           1 (2%)                                             
      Clear Cell Focus                                 1 (2%)                                                                       
      Eosinophilic Focus                                                         1 (2%)                                             
      Infarct                                                       1 (5%)                                                          
      Necrosis                                         9 (18%)      4 (18%)      2 (4%)                                             
      Thrombosis                                                    1 (5%)                                                          
   Pancreas                                           (45)         (16)         (49)                                                
      Inflammation, Chronic                           16 (36%)      1 (6%)      11 (22%)                                            
      Vacuolization Cytoplasmic                       12 (27%)      2 (13%)      8 (16%)                                            
      Duct, Dilatation                                                           1 (2%)                                             
   Salivary Glands                                    (50)         (17)         (49)                                                
      Inflammation, Chronic Active                    33 (66%)      7 (41%)     21 (43%)                                            
   Stomach, Forestomach                               (46)         (19)         (48)                                                
      Acanthosis                                       1 (2%)                                                                       
      Diverticulum                                     1 (2%)                                                                       
      Hyperkeratosis                                   1 (2%)                                                                       
   Stomach, Glandular                                 (46)         (16)         (47)                                                
      Hyperplasia                                                   1 (6%)                                                          
      Inflammation, Chronic                            9 (20%)      1 (6%)       8 (17%)                                            
      Mineralization                                   2 (4%)       1 (6%)       4 (9%)                                             
   Tooth                                              (9)          (1)          (6)                                                 
      Dysplasia                                        9 (100%)     1 (100%)     5 (83%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05057-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            HC YELLOW 4                                        Date: 09/08/94  
Route: DOSED FEED                                                                                                 Time: 06:16:55  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATE     0.5%         1.O%                                                   
                                                   D 61UM       61LM         61HM                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (17)         (49)                                                
      Abscess                                          1 (2%)                                                                       
      Inflammation, Chronic                            8 (16%)                   7 (14%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (17)         (48)                                                
      Hyperplasia                                      7 (14%)      1 (6%)       7 (15%)                                            
   Adrenal Gland, Medulla                             (50)         (16)         (47)                                                
      Hyperplasia                                      1 (2%)                    2 (4%)                                             
   Islets, Pancreatic                                 (45)         (15)         (49)                                                
      Hyperplasia                                      8 (18%)                                                                      
   Pituitary Gland                                    (38)         (13)         (40)                                                
      Pars Distalis, Cyst                              1 (3%)       1 (8%)                                                          
      Pars Distalis, Hyperplasia                      10 (26%)      1 (8%)       6 (15%)                                            
   Thyroid Gland                                      (47)         (48)         (49)                                                
      Inflammation, Chronic                                         7 (15%)     29 (59%)                                            
      Follicle, Cyst                                                             2 (4%)                                             
      Follicle, Inflammation, Acute                                 1 (2%)                                                          
      Follicle, Pigmentation                                       44 (92%)     48 (98%)                                            
      Follicular Cell, Hyperplasia                                 27 (56%)     41 (84%)                                            
      Follicular Cell, Pigmentation                                44 (92%)     49 (100%)                                           
      Interstitium, Pigmentation                                   42 (88%)     49 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (47)         (49)                                                
      Granuloma Sperm                                  1 (2%)                    1 (2%)                                             
      Inflammation, Chronic Active                    16 (32%)     13 (28%)     13 (27%)                                            
   Penis                                              (5)          (8)          (4)                                                 
      Inflammation, Chronic Active                     3 (60%)      4 (50%)      2 (50%)                                            
   Preputial Gland                                    (9)          (11)         (6)                                                 
      Abscess                                          3 (33%)      3 (27%)      1 (17%)                                            
      Inflammation, Chronic Active                     5 (56%)      8 (73%)      4 (67%)                                            
      Duct, Dilatation                                 1 (11%)                                                                      
   Prostate                                           (47)         (15)         (45)                                                
      Inflammation, Chronic Active                    34 (72%)      7 (47%)     20 (44%)                                            
   Seminal Vesicle                                    (49)         (21)         (49)                                                
      Inflammation, Chronic Active                    11 (22%)      4 (19%)     14 (29%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05057-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            HC YELLOW 4                                        Date: 09/08/94  
Route: DOSED FEED                                                                                                 Time: 06:16:55  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATE     0.5%         1.O%                                                   
                                                   D 61UM       61LM         61HM                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
   Testes                                             (50)         (17)         (49)                                                
      Spermatogenic Arrest                                          1 (6%)       1 (2%)                                             
      Germinal Epithelium, Giant Cell                               1 (6%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Spleen                                             (49)         (21)         (48)                                                
      Depletion Lymphoid                              11 (22%)      9 (43%)      5 (10%)                                            
      Hematopoietic Cell Proliferation                 6 (12%)      6 (29%)      5 (10%)                                            
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
   Thymus                                             (28)         (9)          (29)                                                
      Cyst                                             8 (29%)      1 (11%)      4 (14%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (49)         (32)         (48)                                                
      Cyst Epithelial Inclusion                        1 (2%)                                                                       
      Inflammation, Chronic Active                     8 (16%)      4 (13%)      5 (10%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (39)         (48)                                                
      Joint, Tarsal, Hyperostosis                     17 (34%)     24 (62%)     17 (35%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (18)         (49)                                                
      Thalamus, Mineralization                        29 (58%)      6 (33%)     25 (51%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (29)         (49)                                                
      Crystals                                                      1 (3%)                                                          
      Alveolar Epithelium, Hyperplasia                 1 (2%)                    3 (6%)                                             
      Bronchiole, Epithelium, Hyperplasia                                        1 (2%)                                             
   Nose                                               (49)         (14)         (47)                                                
      Cyst                                             1 (2%)                                                                       
      Inflammation, Acute                              6 (12%)                   3 (6%)                                             
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05057-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            HC YELLOW 4                                        Date: 09/08/94  
Route: DOSED FEED                                                                                                 Time: 06:16:55  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATE     0.5%         1.O%                                                   
                                                   D 61UM       61LM         61HM                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (22)         (49)                                                
      Abscess                                          2 (4%)                                                                       
      Cyst                                             1 (2%)                    3 (6%)                                             
      Hydronephrosis                                   1 (2%)                    1 (2%)                                             
      Inflammation, Chronic Active                    38 (78%)     15 (68%)     44 (90%)                                            
      Necrosis                                         1 (2%)                                                                       
      Vacuolization Cytoplasmic                                     1 (5%)                                                          
      Papilla, Mineralization                                                    1 (2%)                                             
      Renal Tubule, Mineralization                     7 (14%)      2 (9%)       4 (8%)                                             
   Urethra                                            (1)          (1)                                                              
      Inflammation, Chronic Active                     1 (100%)     1 (100%)                                                        
   Urinary Bladder                                    (44)         (17)         (50)                                                
      Calculus Micro Observation Only                               1 (6%)       1 (2%)                                             
      Hemorrhage                                                    2 (12%)                                                         
      Inflammation, Chronic Active                    28 (64%)      5 (29%)     25 (50%)                                            
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------